Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell lines.

TURNER, Sharon L., MANGNALL, David, BIRD, Nigel C., BUNNING, Rowena and BLAIR-ZAJDEL, Maria E. (2012). Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell lines. International Journal of Oncology, 41 (3), 1043-1049.

Full text not available from this repository.
Official URL: http://www.spandidos-publications.com/ijo/41/3/104...
Link to published version:: 10.3892/ijo.2012.1525

Abstract

Little is known about the expression or role of ADAMTS-1, -4 and -5 and their endogenous inhibitor TIMP3 in the liver in physiological and pathological conditions. Their expression was, therefore, investigated in the hepatocellular carcinoma cell lines HepG2 and HuH-7 using qRT-PCR and western blotting, and their cellular localisation by immunocytochemistry. Cytokine treatments were used to assess mRNA and protein modulation. ADAMTS-1, -4, -5 and TIMP3 mRNA and protein were detected in both HepG2 and HuH-7 cells. IL-1β and IL-6 treatments significantly modulated ADAMTS-1 mRNA expression and IL-1β treatment ADAMTS-4 mRNA expression in HepG2 cells. Modulations of mRNA by ≥ 5-fold did not translate to increased protein expression. This study showed that ADAMTS-1, -4, -5 and TIMP3 were expressed at differential levels in hepatocellular carcinoma cell lines. The pro-inflammatory cytokines IL-1β, TNF-α or IL-6 induced changes in mRNA expression, although these did not translate to the protein level.

Item Type: Article
Research Institute, Centre or Group: Biomolecular Sciences Research Centre
Identification Number: 10.3892/ijo.2012.1525
Depositing User: Marguerite Lyons
Date Deposited: 02 Aug 2013 12:51
Last Modified: 02 Aug 2013 12:51
URI: http://shura.shu.ac.uk/id/eprint/7179

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics